Famille C is the family investment office of the Courtin-Clarins family, founders of the Clarins luxury cosmetics group. It invests across the beauty, wellness, beauty-tech, and luxury hospitality sectors, supporting brands, tech tools, and scientific innovations at early- and growth-stage.
33% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $34.9M (across 5 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
AC
Alexis Cazier
Partner
CT
Caroline Tazi
Investment & Portfolio Director
SL
Simon Louis
Investment Analyst
PC
Prisca Courtin
Directrice générale
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Spore Biotechnologies | Series A | — | Feb 2025 |
 Spore | Series A | $23M | Jan 2025 |
 Spore.Bio | Series A | $23M | Jan 2025 |
| Spore.Bio | Pre-Seed | — | Jan 2024 |
| Spore | Pre-Seed | $8.3M | Jan 2023 |
 Le Collectionist | Unknown | — | Dec 2022 |
 Lumapps | Series C | $70M | Jan 2020 |
 Launchmetrics | Unknown | $50M | Jan 2018 |
| Lumapps | Growth | — | — |
Top Co-Investors
Station F5 shared
No Label Ventures5 shared
Phoenix Court Group5 shared
Singular3 shared
Point 723 shared
1st Kind Ventures3 shared
Bpifrance3 shared
Goat Capital2 shared
Better Angle2 shared
The Goldman Sachs Group, Inc.2 shared
Iris Capital2 shared
Idinvest Partners2 shared
Plug and Play Tech Center1 shared
Redpoint Ventures1 shared
Point72 Asset Management1 shared
Red River West1 shared
Highland Europe1 shared
XAnge1 shared
Serena1 shared
Seventure Partners1 shared
Last updated: 20 October 2026